Aligos Therapeutics (ALGS) Stock Chart & Stock Price History $7.59 -0.06 (-0.78%) Closing price 04:00 PM EasternExtended Trading$7.83 +0.24 (+3.16%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Aligos Therapeutics Stock Price Performance The Aligos Therapeutics (ALGS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 38.42%, with a year-to-date return of -80.95%. In the past month, the stock has decreased 12.66%, reflecting recent market activity. As of the latest close, Aligos Therapeutics traded at $7.65 with a market cap of $46.74 million and volume of 57,884 shares. Receive ALGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.30%1 Month Performance-12.66%3 Month Performance+36.51%Year-To-Date Performance-80.95%1 Year Performance-38.42% ALGS Stock Chart for Thursday, August, 14, 2025 ALGS Chart by TradingView Aligos Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$7.65$7.59-0.78%$7.85$7.3537,062 shs$46.38 million08/13/2025$7.43$7.65+2.96%$7.77$7.3057,884 shs$46.74 million08/12/2025$7.57$7.43-1.85%$7.97$7.4455,288 shs$45.40 million08/11/2025$7.69$7.57-1.56%$7.97$7.3051,106 shs$46.25 million08/08/2025$8.13$7.69-5.41%$8.49$7.5484,987 shs$46.99 million08/07/2025$8.04$8.13+1.12%$8.24$7.09113,874 shs$49.71 million08/06/2025$7.91$8.04+1.64%$8.42$7.5760,046 shs$49.12 million08/05/2025$8.00$7.91-1.13%$8.22$7.4547,794 shs$48.33 million08/04/2025$7.46$8.00+7.24%$8.00$7.4228,705 shs$48.91 million08/01/2025$7.28$7.46+2.47%$7.96$7.0149,221 shs$45.61 million Get the Latest News and Ratings for ALGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$7.93$7.28-8.20%$8.18$7.2758,084 shs$44.48 million07/30/2025$8.04$7.93-1.37%$8.55$7.7049,068 shs$48.45 million07/29/2025$8.76$8.04-8.22%$8.98$8.0175,020 shs$49.16 million07/28/2025$9.13$8.76-4.05%$9.25$8.7041,347 shs$53.52 million07/25/2025$8.91$9.13+2.47%$9.20$8.5847,451 shs$55.78 million07/24/2025$9.28$8.91-3.99%$9.11$8.6738,504 shs$54.44 million07/23/2025$9.12$9.28+1.75%$9.44$8.9446,007 shs$56.74 million07/22/2025$8.64$9.12+5.56%$9.22$8.1881,117 shs$55.72 million07/21/2025$9.16$8.64-5.68%$9.92$8.64170,696 shs$52.79 million07/18/2025$9.04$9.16+1.33%$9.48$8.8479,665 shs$55.97 million07/17/2025$8.68$9.04+4.15%$9.30$8.61131,332 shs$55.23 million07/16/2025$8.50$8.68+2.12%$8.69$8.2056,517 shs$53.07 million07/15/2025$8.69$8.50-2.19%$8.95$8.2650,714 shs$51.94 million07/14/2025$8.36$8.69+3.95%$8.80$8.1355,283 shs$53.10 million Related Companies Caribou Biosciences Stock Chart Cybin Stock Chart Organigram Global Stock Chart DiaMedica Therapeutics Stock Chart Cardiff Oncology Stock Chart Rapt Therapeutics Stock Chart Lyell Immunopharma Stock Chart Aclaris Therapeutics Stock Chart SELLAS Life Sciences Group Stock Chart Cellectis Stock Chart Receive ALGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALGS) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aligos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access